arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Bodhi Tree Biotechnology Inc

BDTB
— Price unavailable
Industrials ·Services-Management Consulting Services ·USServices-Management Consulting Services
2 Visible periods
15 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bodhi Tree Biotechnology Inc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -125.6%
FCF / Share $-0.01
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
6
Cash Quality
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 2 years · 10 quarters